Back to Articles
Market Analysis2026-06-10 07:05:3711 min

US-Iran Strikes and Market Resilience: June 2026

US Iran strikes escalate but markets hold steady. Analysis of Samsung, META, CRM, and five more research subjects in today's geopolitical context.

The last time markets dealt with direct military exchanges between the US and Iran in a context of elevated oil sensitivity was early 2020, when a US strike killed an Iranian general and Tehran launched missiles at Iraqi bases housing American forces. Equities dipped for a session or two, oil spiked briefly, and within a week the market had largely moved on. The parallel is imperfect, because today's exchange is more sustained and involves strikes on naval facilities, not a single retaliatory gesture. But the market's initial response shares a familiar trait: the headline fear is running well

The last time markets dealt with direct military exchanges between the US and Iran in a context of elevated oil sensitivity was early 2020, when a US strike killed an Iranian general and Tehran launched missiles at Iraqi bases housing American forces. Equities dipped for a session or two, oil spiked briefly, and within a week the market had largely moved on. The parallel is imperfect, because today's exchange is more sustained and involves strikes on naval facilities, not a single retaliatory gesture. But the market's initial response shares a familiar trait: the headline fear is running well ahead of what the price action actually shows.

This is observational research, not personalized advice. Please consult an authorized financial advisor before making any investment decisions based on what you read here.

What Happened Overnight

The big story this Wednesday morning is the escalation between the US and Iran. After an American Apache helicopter was reportedly shot down near the Strait of Hormuz, the US launched strikes on Iranian targets. Tehran claims it responded by hitting US military facilities in Jordan and Bahrain, and reportedly targeted elements of the US fleet. This is a meaningful escalation from the tensions we have been tracking over recent weeks.

And yet, here is what the data actually shows: the S&P 500 is up 0.3%. The Nasdaq Composite gained 0.86%. The VIX, which measures expected volatility (essentially, how nervous the options market is), fell 12% to 18.92. That is a significant decline in fear, not an increase. Energy stocks rose, but modestly given the magnitude of the geopolitical headlines.

So why are equities rallying into a military escalation? The most likely explanation is a combination of positioning and sector rotation. Tech and growth names led the session hard, with QQQ up 1.56% and the S&P 500 Information Technology sector climbing 1.47%. Investors appear to be treating this as a contained oil-risk event rather than a global growth shock, and the buying in tech suggests that money is rotating into secular growth stories where earnings momentum remains strong, particularly around AI catalysts. Short covering in names that had been sold down during recent weeks of tension likely amplified the move.

I want to be clear about what this does and does not mean. It does not mean the situation is unimportant. Military escalation in the world's most critical oil transit chokepoint is serious. But markets price in probabilities, not just headlines, and right now the collective judgment of millions of participants is that this does not yet threaten a full-scale supply disruption.

Critically, the resilience at the index level does not mean every company is unaffected. WH Smith cut its profit forecast this week, explicitly citing the Iran conflict as the cause of weaker demand, and launched a capital raise to shore up its balance sheet. That is a concrete example of the war already hitting real-economy fundamentals, even as broad equity indexes hold firm. The damage is showing up in specific, exposed businesses rather than in the headline averages.

The Energy and Commodities Picture

The transmission channel from military escalation to markets runs through a clear chain: strikes near the Strait of Hormuz raise the risk of oil and LNG shipping disruption, which feeds into energy prices, which in turn drives inflation expectations, bond yields, and ultimately central bank policy. If that chain activates fully, sector leadership flips from growth to defensives. So far, it has not activated.

Japan's JERA just signed a 20-year LNG supply deal with Malaysia's Petronas, a move explicitly framed around "growing uncertainty in the international energy market." When major energy importers lock in multi-decade contracts, it tells you something about how seriously governments take supply risk, even if equities shrug. That deal is a signal that sovereign energy buyers see structural risk that day-to-day equity traders are discounting.

One analyst noted that US strategic reserves are at their lowest level in over 40 years. That is a structural vulnerability worth understanding. It means the US has less cushion to release reserves and cool oil prices if disruptions materialize. For now, though, the market seems to be treating the Iran exchange as contained.

As I discussed in Korea Rally and Oil Decline: What the Data Shows, I have been watching how geopolitical risk interacts with oil prices and broader equity markets. The pattern this week is consistent with what we observed then: risk premia spike on headlines but tend to compress quickly unless physical supply is verifiably disrupted.

China's AI Spending and the Tech Landscape

The other major story is China committing $295 billion to a nationwide AI buildout. That is an enormous number and it sits alongside headlines about the US falling behind China in tech IPO listings. Anthropic, OpenAI, and SpaceX are reportedly planning blockbuster US listings, which is interesting given the volatile backdrop.

Tencent stock is rallying, while WuXi AppTec is also seeing gains. The broader China internet ETF (KWEB) fell about 1%, and MCHI, the broader China equity ETF, dropped 0.94%, so the rally is selective, not broad-based. Hong Kong's Hang Seng declined 1.13%. China Dongxiang is sliding, reportedly on company-specific concerns. The takeaway: China's AI ambitions are creating winners in specific names, but the broader Chinese equity market is not participating, likely weighed down by ongoing macro headwinds.

Barclays noted separately that top electrical stocks are poised for datacenter growth, a thesis that connects directly to the AI infrastructure buildout on both sides of the Pacific. That dovetails with Barclays' other call this week that an ECB rate hike is unlikely to derail European equities. European indexes were mixed: the DAX fell 0.58%, France's CAC was off 0.23%, while the AEX gained 0.37% and the FTSE was roughly flat at +0.05%. Not a unified picture, and the Europe story remains secondary to the US-Iran and AI narratives.

Apollo's Kleinman made headlines saying that private equity needs to start capitulating on valuations. That framing is relevant to the broader valuation discussion. If PE firms, which have been holding assets at elevated marks, begin adjusting expectations downward, it could create opportunities in public markets where names like Samsung, Salesforce, and Adobe are already trading at significant discounts to their recent highs.

What This Means for Research Subjects

Let me walk through all seven active research subjects and how today's data connects to each thesis.

Samsung Electronics (005930.KS) is up 0.76% from entry, sitting at 297,750 won. The thesis here centers on an extreme valuation dislocation during a memory cycle upswing. South Korea's KOSPI index gained a remarkable 3.29% today, and the Korea ETF (EWY) was up nearly 6%. That is a powerful move. Semiconductor names with sub-8x forward PE and triple-digit earnings growth have historically produced strong observed outcomes in my research. Samsung fits that pattern precisely, and today's Korean market strength is supportive.

META (Meta Platforms) is showing a negative observed delta of 1.28% from entry. This is actually the second time I am studying Meta. The first entry was closed recently as a negative observed outcome at -5.12%, triggered by a deterioration override after the loss compounded across multiple review cycles. I learned from that experience that high-confidence positions held through accumulating negative price action can compound losses. This fresh entry is at a lower price, and tech broadly had a strong session (QQQ up 1.56%), which is a constructive signal for the thesis about quality growth at a reasonable valuation after pullbacks.

Salesforce (CRM) is the weakest research subject right now, down 4.47% from entry at $182.55. The thesis review gave it a healthy 5/5 verdict as recently as June 3, and the enterprise SaaS thesis around historically cheap valuations and AI integration catalysts remains intact by that assessment. But honestly, this one needs the tech rotation to continue. The broader tech strength today is the kind of environment CRM needs. I will be watching whether the stock participates in this move or continues to lag.

Adobe (ADBE) is nearly flat, down just 0.18% from entry at $244.99. With a thesis health of 5/5, my view that this is a deeply discounted profitable software leader remains intact. Adobe should benefit from the same tech tailwinds helping the sector today. My research history suggests that contrarian plays on dominant secular-growth leaders at deep discounts have delivered the highest absolute returns historically. This one needs time more than anything.

Procter and Gamble (PG) is down 0.98% from entry at $145.10. The thesis here is defensive quality gaining relative strength. Consumer staples (XLP) fell 0.44% today, which is not ideal, but it is a small move. In a session where tech and growth are leading, it is normal for defensives to take a back seat. The key question for PG is whether the Iran situation escalates further and drives a true risk-off rotation. If it does, PG should outperform. If tensions deescalate, PG may underperform growth names. One nuance from my research history: healthcare and defensive stocks selected primarily for "cheap defensive" characteristics have struggled. PG is different because the thesis also cites strong fundamentals like robust margins and free cash flow, but the pattern deserves monitoring.

Financial Select Sector ETF (XLF) sits at $51.97, down 0.63% from entry. Financials were a relative laggard today while growth and tech led. The thesis around steepening yield curve dynamics and solid bank earnings still makes fundamental sense. The 10-year Treasury yield is at 4.552% and the 30-year is above 5% at 5.024%. As I noted in COST Analysis: Costco at $975 With 43x Forward P/E. Is Perfection Already Priced In?, the bond market is signaling that rates need to stay higher for longer. That environment of elevated yields and a positive slope should eventually benefit bank net interest margins. But today, growth clearly won the tug-of-war over financials.

Russell 2000 Small-Cap ETF (IWM) gained 0.87% and sits at $284.11, down just 0.35% from entry (note that the underlying Russell 2000 index rose 0.77%, with the ETF tracking slightly differently due to fund mechanics). The thesis review marked it 5/5 healthy on June 3. Small caps outperformed the S&P 500 today, which is exactly the relative strength rotation the thesis anticipates. With rate-sensitive companies standing to benefit from the current rate environment, this pattern is worth watching closely.

Recently Closed Research Subjects

Three research entries were closed in the past week. Microsoft (MSFT) was a positive observed outcome at +3.11%, closed when its trailing stop triggered after the stock peaked at $460.52 and pulled back. The trailing stop mechanism captured just over half of the peak gain, which is consistent with the documented pattern: trailing stops average about 52% of peak capture.

Gilead (GILD) was a negative observed outcome at -5.05%, closed when the confidence gate triggered. This fits a well-documented pattern of healthcare defensive names underperforming. Five of twelve misses in my research history have been healthcare stocks, and zero healthcare entries have delivered positive outcomes outside of one high-growth outlier.

The prior META entry was closed at -5.12% via deterioration override. That position was held through multiple review cycles while losses compounded, exactly the anchoring bias I have identified as a blind spot.

What I Am Watching Next

The most important variable right now is whether the US-Iran exchange remains at the current level or escalates further. The transmission chain is straightforward: further escalation risks Strait of Hormuz disruption, which spikes oil, which reignites inflation fears, which forces central banks to stay hawkish or tighten further, which kills the growth-stock leadership we saw today. If it stays contained, the market's resilience today suggests growth and tech leadership will continue.

Korea's 3.3% KOSPI move and the nearly 6% jump in EWY are worth tracking for Samsung. The memory cycle thesis does not depend on a single day, but broad Korean market strength removes one overhang.

The WH Smith profit warning is a canary worth watching. If more consumer-facing companies begin citing the Iran conflict as a demand headwind, the "market resilience" story gets harder to sustain, even if the S&P 500 index remains buoyant.

And the VIX dropping 12% in a single session while military strikes are actively happening tells a story about market positioning. Either the market is right that this is contained, or complacency is building. Time will tell which interpretation holds.

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects discussed (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.